Arthritis Activity Limitations Affect Nearly Half of US Adults
Key Clinical Summary
- Nearly half (47.8%) of US adults with doctor-diagnosed arthritis reported activity limitations in 2023.
- Prevalence of arthritis-attributable activity limitations (AAAL) declined slightly from 2019 to 2023, but the change was not statistically significant.
- The Healthy People 2030 goal of reducing AAAL to 46.8% has not been achieved, highlighting ongoing unmet needs.
Arthritis continues to impose substantial functional burdens on US adults, with activity limitations affecting nearly half of those diagnosed, according to data from the National Health Interview Survey (NHIS).
Study Findings
Using cross-sectional NHIS data from 2019 and 2023, investigators estimated the prevalence of AAAL among adults with doctor-diagnosed arthritis. In 2023, approximately 24.8 million adults reported activity limitations related to arthritis, translating to an age-adjusted prevalence of 47.8% (95% CI, 45.0%-50.7%).
Researchers evaluated differences by sociodemographic and health characteristics and found significant variation in age-adjusted AAAL prevalence across subgroups, indicating disparities in functional impact. While the age-adjusted prevalence decreased slightly from 49.2% (95% CI, 46.7%-51.6%) in 2019 to 47.8% in 2023, this reduction was not statistically significant, suggesting limited progress toward improving functional outcomes among patients with arthritis.
The findings underscore the persistent burden of arthritis-related disability and signal that the Healthy People 2030 objective—to reduce AAAL prevalence to 46.8%—remains unmet. Investigators noted that targeted, evidence-based interventions are needed to drive measurable improvements in activity levels and functional health.
Clinical Implications
For clinicians, managed care organizations, and payers, the findings highlight the ongoing impact of arthritis on patient functioning and health system utilization. Activity limitations are closely linked to increased health care use, work disability, and reduced quality of life, all of which contribute to higher overall costs of care.
The lack of statistically significant improvement between 2019 and 2023 suggests that current public health and clinical management strategies may be insufficient to meaningfully reduce disability burden. Evidence-based arthritis interventions—including physical activity programs, self-management education, and multidisciplinary care—could help improve functional outcomes and reduce downstream utilization.
Payers and health systems may consider investing in population health strategies that integrate rehabilitation, behavioral support, and preventive care for patients with arthritis. Addressing disparities identified across sociodemographic groups may also help advance equity-focused health outcomes and align with Healthy People 2030 benchmarks.
Investigators emphasized that organizations working independently or collaboratively can help reduce AAAL prevalence by implementing arthritis-appropriate, evidence-based interventions. Such efforts, they noted, are essential for progressing toward national health objectives and improving functional outcomes among adults with arthritis.
Conclusion
Nearly half of US adults with arthritis continue to experience activity limitations, and national targets to reduce this burden have not been achieved. Expanded adoption of evidence-based interventions and coordinated population health strategies may be critical to improving mobility, quality of life, and health outcomes in this growing patient population.
Reference
- Stowe EW, White DK, Boring MA, Barbour KE, Lites TD, Fallon EA. Prevalence of arthritis-attributable activity limitations - United States, 2023. Arthritis Care Res (Hoboken). 2025 Dec 15. doi:10.1002/acr.70018
- Volansky R. Arthritis-associated activity limitations reported in more than 24 million US adults. Healio Rheumatology. January 27, 2026. Accessed March 3, 2026. https://www.healio.com/news/rheumatology/20260126/arthritisassociated-activity-limitations-reported-in-more-than-24-million-us-adults
